Evaluation Of The Chronic Effects Of Covıd-19 Infection On The Respiratory System
NCT ID: NCT06439134
Last Updated: 2024-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-06-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Volunteers who recovered from COVID-19 and those who didn't have COVID-19 were compared by evaluating chest x-ray scores (CXR), lung ultrasound scores (LUSS), pulmonary function tests and inflammatory cytokine levels (TNF-α, IL-1, IL-6, IL-17A).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196
Long Term Outcomes of Coronavirus Disease-19 (COVID-19)
NCT04715919
Pulmonary and Extrapulmonary Impairments in Patients With Post COVID-19
NCT05381727
Global Impact of COVID-19 on Pulmonology Special Units
NCT04554251
Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19
NCT04610554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Methods: Volunteers who recovered from COVID-19 infection at least 3 months or more were included in the study, while healthy volunteers who did not have the infection were enrolled as the control group. Two groups were compared by evaluating chest x-ray scores (CXR), lung ultrasound scores (LUSS), pulmonary function tests and inflammatory cytokine levels (TNF-α, IL-1, IL-6, IL-17A).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-COVID-19 group
The group which consists of volunteers who has not been infected by COVID-19 virus
Pulmonary Ultrasound, Respiratory Function Test
Volunteers underwent pulmonary ultrasound and respiratory function test
Post COVID-19 group
The group which consists of volunteers who has been infected by COVID-19 virus and has at least 3 months or more post-COVID period
Pulmonary Ultrasound, Respiratory Function Test
Volunteers underwent pulmonary ultrasound and respiratory function test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary Ultrasound, Respiratory Function Test
Volunteers underwent pulmonary ultrasound and respiratory function test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not having had COVID-19 infection
* (For female patients) No pregnancy or puerperium
* Consent for the study
* To be able to complete the pulmonary function test successfully
* Vital signs at the stage of lung ultrasound or pulmonary function testing during the study no change in findings
* Not having an active infection at the time of the workplace examination
* No abnormal findings in the chest radiograph taken before the study
* Absence of existing autoimmune or rheumatological disorders For the experimental group;
* Age range: Being between 18-60 years old
* Having had COVID-19 infection and post infectious period of 3 months or more to be
* (For female patients) No pregnancy or puerperium
* Consent for the study
* To be able to complete the pulmonary function test successfully
* Vital signs at the stage of lung ultrasound or pulmonary function testing during the study no change in findings
* Not having an active infection at the time of the workplace examination
* Abnormal findings on chest radiography taken in the pre-infectious period before the study absence of
* Absence of existing autoimmune or rheumatological disorders
Exclusion Criteria
* (for the experimental group) COVID-19 infection and 3 days of post infectious period under the month
* (For female patients) Pregnancy or puerperium
* Lack of consent for the study
* Failure to complete the pulmonary function test (dizziness, incompatibility, etc.) reasons)
* Vital signs at the stage of lung ultrasound or pulmonary function testing during the study change in findings
* Having an active infection at the time of the workplace examination
* Abnormal chest radiographs taken in the pre-infectious period before the study the presence of findings
* Existing autoimmune or rheumatological disease
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yeditepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yeditepe University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Inflammation and Post COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.